Protein Engineering & Services
Publication date: 5 December, 2024
Protein Engineering
Hot topics in Protein Engineering & Drug Development Services
Engineered biological antibodies such as bispecific antibodies, ADCs, radiopharmaceuticals, antibody fragments, synthetic peptide-hormone combinations or chimeric antigen receptors are currently transforming medicine due to their superior target specificity, pharmacokinetic and pharmacodynamic properties, safety and toxicity profiles. Last year, these biologics accounted for 48% of FDA approvals. European Biotechnology will report on the latest advances in AI-driven antibody design, analytical characterisation, formulation, targeting and delivery, process development and related services (i.e. preclinical drug development) from the best biologics technology meeting in 2024: the PEGS Europe in Barcelona. Gain visibility in this interesting editorial environment and present your offer/portfolio to customers.
Present your expertise
Drug developers, CROs, process developers, analytical experts, formulation specialists, providers of research equipment, AI and ML companies, as well as experts in emerging areas will have the opportunity to present their latest developments, products, services, and equipment in this special. EuropEan BiotEchnology goes out to decision makers throughout the entire European Life Sciences sectors. Take advantage of the journal’s highly relevant readership and grab this opportunity to target your audience!
Topics to be covered
Protein Engineering/Conjugates/ Services: Antibody conjugation, multispecifics engineering, CAR-engineering and expression, analytical testing, formulation and optimisation, pre/clinical development, QS, process development, automation, manufacturing, challenges with ADCs, radio-conjugates, delivery strategies, TME targeting, equipment, automated screening, glyco-engineering, stratification, drug discovery services, immunooncology, biomarker/drug approval, animal/organoid models, AI tools, your platform, and more.
Editorial Deadline 20-11-2024
Editorial Contact:
Booking Deadline 22-11-2024
Marketing Contact:
Publication Date 05-12-2024
Marketing Contact: Thomas Gabrielczyk Oliver Schnell Andreas Macht
Tel.: +49-30-264921-50
Fax: +49-30-264921-11
t.gabrielczyk@biocom.de
Tel.: +49-30-264921-45
Fax: +49-30-264921-11
o.schnell@biocom.de
Tel.: +49-30-264921-54
Fax: +49-30-264921-11
a.macht@biocom.de
Special: Protein Engineering & Services
Europe: european-biotechnology.net European Biotechnology Network
Austria: lifescienceaustria.at
United States: slas.org
Europe: medicinesforeurope.com
Germany: gasb.de
Ireland: ibec.ie/ibia
Portugal: www.p-bio.org
Italy: assobiotec.it
Spain: asebio.com
Switzerland: swissbiotech.org
Sweden: swedenbio.com
Young European Biotech Network
Europe: yebn.eu
Austria: biotechaustria.org
Norway: biotekforum.no
EuropE
Denmark: danskbiotek.dk The Netherlands: hollandbio.nl
UK: biopartner.co.uk
France: france-biotech.org
Hungary: hungarianbiotech.org
Europe: cebr.net
Finland: finbio.net Belgium: bio.be